Lineagen has developed a comprehensive intellectual property portfolio including patent applications in autism, multiple sclerosis, and COPD. This portfolio includes biological markers with both therapeutic and diagnostic applications. In addition to developing these diagnostic applications, Lineagen is seeking collaborative and partnership opportunities to further develop these assets.

Please contact our Business Development Department at bd@lineagen.com if you are interested in learning more about partnering opportunities with Lineagen.